47 results on '"Hoornaert C"'
Search Results
2. Modulation of CNS immune responses in multiple sclerosis: stem cells versus IL-13 immuno gene therapy?: OP-063
- Author
-
Ponsaerts, P, Praet, J, Le Blon, D, Guglielmetti, C, Reekmans, K, De Vocht, N, Hoornaert, C, Daans, J, Van der Linden, A, and Berneman, Z
- Published
- 2013
3. NP-009 Patients’ personal treatment management in a university hospital
- Author
-
Hoornaert, C, primary
- Published
- 2019
- Full Text
- View/download PDF
4. Intracerebral delivery of the M2 polarizing cytokine interleukin 13 using mesenchymal stem cell implants in a model of temporal lobe epilepsy in mice
- Author
-
Ali, I, Aertgeerts, S, Le Blon, D, Bertoglio, D, Hoornaert, C, Ponsaerts, P, Dedeurwaerdere, S, Ali, I, Aertgeerts, S, Le Blon, D, Bertoglio, D, Hoornaert, C, Ponsaerts, P, and Dedeurwaerdere, S
- Abstract
OBJECTIVES: Neuroinflammation plays a critical role in the pathophysiology of mesial temporal lobe epilepsy. We aimed to evaluate whether intracerebral transplantation of interleukin 13-producing mesenchymal stem cells (IL-13 MSCs) induces an M2 microglia/macrophage activation phenotype in the hippocampus with an epileptogenic insult, thereby providing a neuroprotective environment with reduced epileptogenesis. METHODS: Genetically engineered syngeneic IL-13 MSCs or vehicle was injected within the hippocampus 1 week before the intrahippocampal kainic acid-induced status epilepticus (SE) in C57BL/6J mice. Neuroinflammation was evaluated at disease onset as well as during the chronic epilepsy period (9 weeks). In addition, continuous video-electroencephalography (EEG) (vEEG) monitoring was obtained during the chronic epilepsy period (between 6 and 9 weeks after SE). RESULTS: Evaluation of vEEG recordings suggested that IL-13 MSC grafts did not affect the severity and duration of SE or the seizure burden during the chronic epilepsy period, when compared to the vehicle treated SE mice. An M2-activation phenotype was induced in microglia/macrophages that infiltrated the -13 MSC graft site, as evidenced by the arginase1 expression at the graft site at both the 2-week and 9-week time-points. However, M2-activated immune cells were rarely observed outside the graft site and, accordingly, the neuroinflammatory response or cell loss related to SE induction was not altered by IL-13 MSC grafting. Moreover, an increase in the proportion of F4/80+ cells was observed in the IL-13 MSC group compared to the controls. SIGNIFICANCE: Our data suggest that MSC-based IL-13 delivery to induce M2 glial activation does not provide any neuroprotective or disease-modifying effects in a mouse model of epilepsy. Moreover, use of cell grafting to deliver bioactive compounds for modulating neuroinflammation may have confounding effects in disease pathology of epilepsy due to the additional immune
- Published
- 2017
5. Synthesis of new chiral phosphines for asymmetric catalysis
- Author
-
Kagan, H. B., primary, Fiaud, J. C., additional, Hoornaert, C., additional, Meyer, D., additional, and Poulin, J. C., additional
- Published
- 2010
- Full Text
- View/download PDF
6. Crystal structure of human mono-glyceride lipase in complex with SAR629
- Author
-
Bertrand, T., primary, Auge, F., additional, Houtmann, J., additional, Rak, A., additional, Vallee, F., additional, Mikol, V., additional, Berne, P.F., additional, Michot, N., additional, Cheuret, D., additional, Hoornaert, C., additional, and Mathieu, M., additional
- Published
- 2010
- Full Text
- View/download PDF
7. In vitro pharmacological profile of SL 87.0495, A new vascular selective calcium channel blocker
- Author
-
Lorrain, J., primary, Grosset, A., additional, Galzin, A.M., additional, Villeneuve, A., additional, Hoornaert, C., additional, Muller, J.C., additional, O'Connor, S.E., additional, and Langer, S.Z., additional
- Published
- 1995
- Full Text
- View/download PDF
8. Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT1B/5-HT2A receptor antagonists
- Author
-
McCort, G., Hoornaert, C., Aletru, M., Denys, C., Duclos, O., Cadilhac, C., Guilpain, E., Dellac, G., Janiak, P., and Galzin, A. M.
- Published
- 2001
- Full Text
- View/download PDF
9. Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction
- Author
-
Galzin, A. M., Delahaye, M., Hoornaert, C., McCort, G., and O'Connor, S. E.
- Published
- 2000
- Full Text
- View/download PDF
10. Modulation of neuroinflammatory responses in the cuprizone mouse model following transplantation of mesenchymal stem cells genetically engineered to secrete IL13 coincides with the appearance of multiple alternatively activated macrophage and microglia phenotypes
- Author
-
Le Blon, D., Guglielmetti, C., Hoornaert, C., Dooley, D., Daans, J., Lemmens, E., Vocht, N., Reekmans, K., Santermans, E., Hens, N., Goossens, H., Verhoye, M., Linden, A., Berneman, Z., Sven Hendrix, and Ponsaerts, P.
11. Interleukin-13 secretion by allogeneic mesenchymal stem cells reduces allograft-specific CD8+T cell activation, induces M2a macrophage polarization, and promotes allogeneic cell graft survival in mice
- Author
-
Hoornaert, C., Luyckx, E., Reekmans, K., Dhainaut, M., Dooley, D., Le Blon, D., Fransen, E., Daans, J., Verbeeck, L., Vocht, N., Lemmens, E., Goossens, H., Annemie Van der Linden, Roobrouck, V., Verfaillie, C., Hendrix, S., Moser, M., Berneman, Z., and Ponsaerts, P.
12. ChemInform Abstract: SYNTHESIS OF NEW CHIRAL PHOSPHINES FOR ASYMMETRIC CATALYSIS
- Author
-
KAGAN, H. B., primary, FIAUD, J. C., additional, HOORNAERT, C., additional, MEYER, D., additional, and POULIN, J. C., additional
- Published
- 1980
- Full Text
- View/download PDF
13. ChemInform Abstract: FREE RADICAL ANNULATION IN THE SYNTHESIS OF BICYCLIC β‐LACTAMS. 1. SYNTHESIS OF 8‐OXO‐5‐OXA‐1‐AZABICYCLO(4.2.0)OCTANE AND 9‐OXO‐6‐OXA‐1‐AZABICYCLO(5.2.0)NONANE DERIVATIVES
- Author
-
BACHI, M. D., primary and HOORNAERT, C., additional
- Published
- 1981
- Full Text
- View/download PDF
14. ChemInform Abstract: DESIGN AND SYNTHESIS OF POTENTIAL MEGACALORIC PARENTERAL NUTRIENTS
- Author
-
HANESSIAN, S., primary, HOORNAERT, C., additional, PERNET, A. G., additional, and NADZAN, A. M., additional
- Published
- 1985
- Full Text
- View/download PDF
15. ChemInform Abstract: CYCLOBUTENYLIDENAMMONIUMSALZE DURCH CYCLOADDITION VON KETENIMINIUMSALZEN AN ACETYLENE
- Author
-
HOORNAERT, C., primary, HESBAIN-FRISQUE, A. M., additional, and GHOSEZ, L., additional
- Published
- 1975
- Full Text
- View/download PDF
16. ChemInform Abstract: FREE RADICAL ANNULATION IN THE SYNTHESIS OF BICYCLIC β-LACTAMS. 3. SYNTHESIS OF 1-OXACEPHEM AND 1-OXAHOMOCEPHEM DERIVATIVES
- Author
-
BACHI, M. D., primary and HOORNAERT, C., additional
- Published
- 1982
- Full Text
- View/download PDF
17. ChemInform Abstract: FREE RADICAL ANNULATION IN THE SYNTHESIS OF BICYCLIC β‐LACTAMS. 4. EXO VS. ENDO CYCLIZATIONS IN THE CONSTRUCTION OF THE (.+‐.)‐1‐OXACEPHAM AND (.+‐.)‐1‐OXAHOMOCEPHAM SYSTEMS
- Author
-
BACHI, M. D., primary, FROLOW, F., additional, and HOORNAERT, C., additional
- Published
- 1983
- Full Text
- View/download PDF
18. ChemInform Abstract: FREE RADICAL ANNULATION IN THE SYNTHESIS OF BICYCLIC β‐LACTAMS. 2. ALTERNATIVE USE OF CHLORO‐, PHENYLSELENO‐, AND PHENYLTHIO FUNCTIONALITIES AS FREE RADICAL PRECURSORS
- Author
-
BACHI, M. D., primary and HOORNAERT, C., additional
- Published
- 1981
- Full Text
- View/download PDF
19. Cyclobutenylidenammoniumsalze durch Cycloaddition von Keteniminiumsalzen an Acetylene
- Author
-
Hoornaert, C., primary, Hesbain-Frisque, A. M., additional, and Ghosez, L., additional
- Published
- 1975
- Full Text
- View/download PDF
20. Cyclobutenylideneammonium Salts from the Cycloadditions of Keteniminium Salts to Acetylenes
- Author
-
Hoornaert, C., primary, Hesbain-Frisque, A. M., additional, and Ghosez, L., additional
- Published
- 1975
- Full Text
- View/download PDF
21. Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain
- Author
-
Jelle Praet, Chloé Hoornaert, Nathalie De Vocht, Ornella Parolini, Roberta Costa, Irene Bergwerf, Jasmijn Daans, Debbie Le Blon, Kristien Reekmans, Zwi N. Berneman, Francesco Alviano, Peter Ponsaerts, Eva Santermans, Niel Hens, Herman Goossens, Costa R, Bergwerf I, Santermans E, De Vocht N, Praet J, Daans J, Blon DL, Hoornaert C, Reekmans K, Hens N, Goossens H, Berneman Z, Parolini O, Alviano F, and Ponsaerts P
- Subjects
Lipopolysaccharides ,Vascular Endothelial Growth Factor A ,Cellular differentiation ,Cell ,Extraembryonic Membranes ,lcsh:Medicine ,Animals ,Brain ,Cell Differentiation ,Cells, Cultured ,Coculture Techniques ,Embryo, Mammalian ,Female ,Fibroblasts ,Immunophenotyping ,Interferon-gamma ,Mice ,Mice, Inbred C57BL ,Microglia ,Stromal Cells ,Transplantation, Homologous ,Tumor Necrosis Factor-alpha ,Inbred C57BL ,angiogenesis ,Settore BIO/13 - BIOLOGIA APPLICATA ,Cultured ,Foetal membrane‐derived stromal cell ,Cell biology ,medicine.anatomical_structure ,Embryo ,Homologous ,Stromal cell ,Cells ,Biomedical Engineering ,Biology ,mmunomodulation ,fetal membrane-derived stromal cells ,embryonic fibroblasts ,immunomodulation ,transplantation ,brain ,In vivo ,medicine ,Fibroblast ,embryonic fibroblast ,Transplantation ,Mammalian ,lcsh:R ,Cell Biology ,Embryonic stem cell ,Molecular biology ,Human medicine - Abstract
Although intracerebral transplantation of various fibroblast(-like) cell populations has been shown feasible, little is known about the actual in vivo remodeling of these cellular grafts and their environment. In this study, we aimed to compare the in vitro and in vivo behavior of two phenotypically similar but developmentally distinct fibroblast-like cell populations, namely, mouse embryonic fibroblasts (mEFs) and mouse fetal membrane-derived stromal cells (mFMSCs). While both mEFs and mFMSCs are readily able to reduce TNF-alpha secretion by LPS/IFN-gamma-activated BV-2 microglia, mFMSCs and mEFs display strikingly opposite behavior with regard to VEGF production under normal and inflammatory conditions. Whereas mFMSCs downregulate VEGF production upon coculture with LPS/IFN-gamma-activated BV-2 microglia, mEFs upregulate VEGF production in the presence of LPS/IFN-gamma-activated BV-2 microglia. Subsequently, in vivo grafting of mFMSCs and IDEFs revealed no difference in microglial and astroglial responses toward the cellular grafts. However, mFMSC grafts displayed a lower degree of neoangiogenesis compared to mEF grafts, thereby potentially explaining the lower cell number able to survive in mFMSC grafts. In summary, our results suggest that physiological differences between fibroblast-like cell populations might lie at the basis of variations in histopathological and/or clinical outcome following cell grafting in mouse brain. This work was supported by research grants G.0136.11 and G.0130.11 (granted to Z.B. and P.P.) of the Fund for Scientific Research-Flanders (FWO-Vlaanderen, Belgium) and in part by a Methusalem research grant from the Flemish government (granted to Z.B. and H.G.). Nathalie De Vocht and Chloe Hoornaert hold a Ph.D.-studentship from the FWO-Vlaanderen. Debbie Le Blon holds a Ph.D.-studentship from the Flemish Institute for Science and Technology (IWT). The authors declare no conflicts of interest.
- Published
- 2015
22. ALCAM on human oligodendrocytes mediates CD4 T cell adhesion.
- Author
-
Jamann H, Desu HL, Cui QL, Halaweh A, Tastet O, Klement W, Zandee S, Pernin F, Mamane VH, Ouédraogo O, Daigneault A, Sidibé H, Millette F, Peelen E, Dhaeze T, Hoornaert C, Rébillard RM, Thai K, Grasmuck C, Vande Velde C, Prat A, Arbour N, Stratton JA, Antel J, and Larochelle C
- Subjects
- Humans, Mice, Animals, CD4-Positive T-Lymphocytes metabolism, Activated-Leukocyte Cell Adhesion Molecule metabolism, Cell Adhesion, Oligodendroglia metabolism, Multiple Sclerosis, Encephalomyelitis, Autoimmune, Experimental
- Abstract
Multiple sclerosis is a chronic neuroinflammatory disorder characterized by demyelination, oligodendrocyte damage/loss and neuroaxonal injury in the context of immune cell infiltration in the CNS. No neuroprotective therapy is available to promote the survival of oligodendrocytes and protect their myelin processes in immune-mediated demyelinating diseases. Pro-inflammatory CD4 Th17 cells can interact with oligodendrocytes in multiple sclerosis and its animal model, causing injury to myelinating processes and cell death through direct contact. However, the molecular mechanisms underlying the close contact and subsequent detrimental interaction of Th17 cells with oligodendrocytes remain unclear. In this study we used single cell RNA sequencing, flow cytometry and immunofluorescence studies on CNS tissue from multiple sclerosis subjects, its animal model and controls to characterize the expression of cell adhesion molecules by mature oligodendrocytes. We found that a significant proportion of human and murine mature oligodendrocytes express melanoma cell adhesion molecule (MCAM) and activated leukocyte cell adhesion molecule (ALCAM) in multiple sclerosis, in experimental autoimmune encephalomyelitis and in controls, although their regulation differs between human and mouse. We observed that exposure to pro-inflammatory cytokines or to human activated T cells are associated with a marked downregulation of the expression of MCAM but not of ALCAM at the surface of human primary oligodendrocytes. Furthermore, we used in vitro live imaging, immunofluorescence and flow cytometry to determine the contribution of these molecules to Th17-polarized cell adhesion and cytotoxicity towards human oligodendrocytes. Silencing and blocking ALCAM but not MCAM limited prolonged interactions between human primary oligodendrocytes and Th17-polarized cells, resulting in decreased adhesion of Th17-polarized cells to oligodendrocytes and conferring significant protection of oligodendrocytic processes. In conclusion, we showed that human oligodendrocytes express MCAM and ALCAM, which are differently modulated by inflammation and T cell contact. We found that ALCAM is a ligand for Th17-polarized cells, contributing to their capacity to adhere and induce damage to human oligodendrocytes, and therefore could represent a relevant target for neuroprotection in multiple sclerosis., (© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
23. Development and Delphi validation of a Best Possible Medication History form.
- Author
-
Hoornaert C, Pochet S, and Lorent S
- Subjects
- Humans, Delphi Technique, Consensus, Reproducibility of Results, Pharmacists
- Abstract
Objective: To develop and validate a standardized Best Possible Medication History (BPMH) form that could be used by clinical pharmacists., Methods: The draft version was presented to a focus group and was adapted following their comments. A three-rounds e-Delphi method was used to validate content, usability and face validity of the BPMH form. We supplemented the quantitative analysis with a qualitative analysis of comments for each Delphi round., Results: The draft BPMH form contained 23 items grouped into eight tabs. Refinement of these tabs and items by the focus group resulted in 7 tabs and 21 items, which were included in the Delphi survey. The consensus was obtained for all tabs within the second round (p=0.072). Consensus was reached on 76% (16/21) of items in the third round. 20 items were included following the qualitative analysis of the experts' comments in the third round., Conclusions: The findings of this study provide data on the content of the BPMH form. This form can be used to help clinical pharmacists to collect a complete and accurate medication list on admission. It could have an impact on inpatient safety and improve inpatient management. Studies with an international e-Delphi should be conducted for wider use., Competing Interests: Competing interests: None declared., (© European Association of Hospital Pharmacists 2023. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
24. Single-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune Encephalomyelitis.
- Author
-
Fournier AP, Tastet O, Charabati M, Hoornaert C, Bourbonnière L, Klement W, Larouche S, Tea F, Wang YC, Larochelle C, Arbour N, Ragoussis J, Zandee S, and Prat A
- Subjects
- Humans, Animals, Mice, Transcriptome, Brain, Endothelium, Encephalomyelitis, Autoimmune, Experimental genetics, Neurodegenerative Diseases, Encephalitis, Multiple Sclerosis genetics
- Abstract
Background and Objectives: Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease characterized by infiltration of immune cells in multifocal areas of the CNS. The specific molecular processes allowing autoreactive immune cells to enter the CNS compartment through the blood-brain barrier remain elusive., Methods: Using endothelial cell (EC) enrichment and single-cell RNA sequencing, we characterized the cells implicated in the neuroinflammatory processes in experimental autoimmune encephalomyelitis, an animal model of MS. Validations on human MS brain sections of the most differentially expressed genes in venous ECs were performed using immunohistochemistry and confocal microscopy., Results: We found an upregulation of genes associated with antigen presentation and interferon in most populations of CNS-resident cells, including ECs. Interestingly, instead of transcriptionally distinct profiles, a continuous gradient of gene expression separated the arteriovenous zonation of the brain vasculature. However, differential gene expression analysis presented more transcriptomic alterations on the venous side of the axis, suggesting a prominent role of venous ECs in neuroinflammation. Furthermore, analysis of ligand-receptor interactions identified important potential molecular communications between venous ECs and infiltrated immune populations. To confirm the relevance of our observation in the context of human disease, we validated the protein expression of the most upregulated genes ( Ackr1 and Lcn2 ) in MS lesions., Discussion: In this study, we provide a landscape of the cellular heterogeneity associated with neuroinflammation. We also present important molecular insights for further exploration of specific cell processes that promote infiltration of immune cells inside the brain of experimental autoimmune encephalomyelitis mice., (Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.)
- Published
- 2022
- Full Text
- View/download PDF
25. Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity.
- Author
-
Hermans D, Houben E, Baeten P, Slaets H, Janssens K, Hoeks C, Hosseinkhani B, Duran G, Bormans S, Gowing E, Hoornaert C, Beckers L, Fung WK, Schroten H, Ishikawa H, Fraussen J, Thoelen R, de Vries HE, Kooij G, Zandee S, Prat A, Hellings N, and Broux B
- Subjects
- Animals, Endothelial Cells metabolism, Endothelial Cells pathology, Mice, Mice, Inbred C57BL, Multiple Sclerosis metabolism, Multiple Sclerosis pathology, Oncostatin M Receptor beta Subunit biosynthesis, Oncostatin M Receptor beta Subunit genetics, Th17 Cells metabolism, Th17 Cells pathology, Blood-Brain Barrier metabolism, Blood-Brain Barrier pathology, Encephalomyelitis, Autoimmune, Experimental genetics, Encephalomyelitis, Autoimmune, Experimental metabolism, Encephalomyelitis, Autoimmune, Experimental pathology, Oncostatin M metabolism, Oncostatin M pharmacology
- Abstract
Oncostatin M (OSM) is an IL-6 family member which exerts neuroprotective and remyelination-promoting effects after damage to the central nervous system (CNS). However, the role of OSM in neuro-inflammation is poorly understood. Here, we investigated OSM's role in pathological events important for the neuro-inflammatory disorder multiple sclerosis (MS). We show that OSM receptor (OSMRβ) expression is increased on circulating lymphocytes of MS patients, indicating their elevated responsiveness to OSM signalling. In addition, OSM production by activated myeloid cells and astrocytes is increased in MS brain lesions. In experimental autoimmune encephalomyelitis (EAE), a preclinical model of MS, OSMRβ-deficient mice exhibit milder clinical symptoms, accompanied by diminished T helper 17 (Th17) cell infiltration into the CNS and reduced BBB leakage. In vitro, OSM reduces BBB integrity by downregulating the junctional molecules claudin-5 and VE-cadherin, while promoting secretion of the Th17-attracting chemokine CCL20 by inflamed BBB-endothelial cells and reactive astrocytes. Using flow cytometric fluorescence resonance energy transfer (FRET) quantification, we found that OSM-induced endothelial CCL20 promotes activation of lymphocyte function-associated antigen 1 (LFA-1) on Th17 cells. Moreover, CCL20 enhances Th17 cell adhesion to OSM-treated inflamed endothelial cells, which is at least in part ICAM-1 mediated. Together, these data identify an OSM-CCL20 axis, in which OSM contributes significantly to BBB impairment during neuro-inflammation by inducing permeability while recruiting Th17 cells via enhanced endothelial CCL20 secretion and integrin activation. Therefore, care should be taken when considering OSM as a therapeutic agent for treatment of neuro-inflammatory diseases such as MS., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
26. DICAM promotes T H 17 lymphocyte trafficking across the blood-brain barrier during autoimmune neuroinflammation.
- Author
-
Charabati M, Grasmuck C, Ghannam S, Bourbonnière L, Fournier AP, Lécuyer MA, Tastet O, Kebir H, Rébillard RM, Hoornaert C, Gowing E, Larouche S, Fortin O, Pittet C, Filali-Mouhim A, Lahav B, Moumdjian R, Bouthillier A, Girard M, Duquette P, Cayrol R, Peelen E, Quintana FJ, Antel JP, Flügel A, Larochelle C, Arbour N, Zandee S, and Prat A
- Subjects
- Animals, Blood-Brain Barrier metabolism, Cell Adhesion Molecules metabolism, Humans, Mice, Natalizumab metabolism, Natalizumab pharmacology, Natalizumab therapeutic use, Neuroinflammatory Diseases, T-Lymphocytes metabolism, Th17 Cells, Multiple Sclerosis drug therapy, Multiple Sclerosis metabolism, Multiple Sclerosis, Relapsing-Remitting
- Abstract
The migration of circulating leukocytes into the central nervous system (CNS) is a key driver of multiple sclerosis (MS) pathogenesis. The monoclonal antibody natalizumab proved that pharmaceutically obstructing this process is an effective therapeutic approach for treating relapsing-remitting MS (RRMS). Unfortunately, the clinical efficacy of natalizumab is somewhat offset by its incapacity to control the progressive forms of MS (PMS) and by life-threatening side effects in RRMS rising from the expression of its molecular target, very late antigen 4 (VLA4), on most immune cells and consequent impairment of CNS immunosurveillance. Here, we identified dual immunoglobulin domain containing cell adhesion molecule (DICAM) as a cell trafficking molecule preferentially expressed by T helper 17 (T
H 17)–polarized CD4+ T lymphocytes. We found that DICAM expression on circulating CD4+ T cells was increased in patients with active RRMS and PMS disease courses, and expression of DICAM ligands was increased on the blood-brain barrier endothelium upon inflammation and in MS lesions. Last, we demonstrated that pharmaceutically neutralizing DICAM reduced murine and human TH 17 cell trafficking across the blood-brain barrier in vitro and in vivo, and alleviated disease symptoms in four distinct murine autoimmune encephalomyelitis models, including relapsing-remitting and progressive disease models. Collectively, our data highlight DICAM as a candidate therapeutic target to impede the migration of disease-inducing leukocytes into the CNS in both RRMS and PMS and suggest that blocking DICAM with a monoclonal antibody may be a promising therapeutic approach.- Published
- 2022
- Full Text
- View/download PDF
27. Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain.
- Author
-
Schirmer L, Hoornaert C, Le Blon D, Eigel D, Neto C, Gumbleton M, Welzel PB, Rosser AE, Werner C, Ponsaerts P, and Newland B
- Subjects
- Brain, Cryogels, Heparin, Interleukin-13
- Abstract
Interleukin-13 (IL-13) drives cells of myeloid origin towards a more anti-inflammatory phenotype, but delivery to the brain remains problematic. Herein, we show that heparin-based cryogel microcarriers load high amounts of IL-13, releasing it slowly. Intra-striatal injection of loaded microcarriers caused local up-regulation of ARG1 in myeloid cells for pro-regenerative immunomodulation in the brain.
- Published
- 2020
- Full Text
- View/download PDF
28. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
- Author
-
Nack A, Brendel M, Nedelcu J, Daerr M, Nyamoya S, Beyer C, Focke C, Deussing M, Hoornaert C, Ponsaerts P, Schmitz C, Bartenstein P, Rominger A, and Kipp M
- Subjects
- Animals, Astrocytes pathology, Astrocytes ultrastructure, Axons metabolism, Axons ultrastructure, Biomarkers metabolism, Cuprizone, Demyelinating Diseases diagnostic imaging, Demyelinating Diseases pathology, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental diagnostic imaging, Encephalomyelitis, Autoimmune, Experimental pathology, Female, Inflammation pathology, Ligands, Mice, Inbred C57BL, Mitochondria metabolism, Mitochondria ultrastructure, Monocytes metabolism, Neuroglia metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Receptors, GABA genetics, Carbazoles metabolism, Multiple Sclerosis diagnostic imaging, Receptors, GABA metabolism
- Abstract
Positron emission tomography (PET) ligands targeting the translocator protein (TSPO) represent promising tools to visualize neuroinflammation in multiple sclerosis (MS). Although it is known that TSPO is expressed in the outer mitochondria membrane, its cellular localization in the central nervous system under physiological and pathological conditions is not entirely clear. The purpose of this study was to assess the feasibility of utilizing PET imaging with the TSPO tracer, [18F]-GE180, to detect histopathological changes during experimental demyelination, and to determine which cell types express TSPO. C57BL/6 mice were fed with cuprizone for up to 5 weeks to induce demyelination. Groups of mice were investigated by [18F]-GE180 PET imaging at week 5. Recruitment of peripheral immune cells was triggered by combining cuprizone intoxication with MOG
35 ⁻ 55 immunization (i.e., Cup/EAE). Immunofluorescence double-labelling and transgene mice were used to determine which cell types express TSPO. [18F]-GE180-PET reliably detected the cuprizone-induced pathology in various white and grey matter regions, including the corpus callosum, cortex, hippocampus, thalamus and caudoputamen. Cuprizone-induced demyelination was paralleled by an increase in TSPO expression, glia activation and axonal injury. Most of the microglia and around one-third of the astrocytes expressed TSPO. TSPO expression induction was more severe in the white matter corpus callosum compared to the grey matter cortex. Although mitochondria accumulate at sites of focal axonal injury, these mitochondria do not express TSPO. In Cup/EAE mice, both microglia and recruited monocytes contribute to the TSPO expressing cell populations. These findings support the notion that TSPO is a valuable marker for the in vivo visualization and quantification of neuropathological changes in the MS brain. The pathological substrate of an increase in TSPO-ligand binding might be diverse including microglia activation, peripheral monocyte recruitment, or astrocytosis, but not axonal injury., Competing Interests: The authors declare no conflict of interest.- Published
- 2019
- Full Text
- View/download PDF
29. Targeted intracerebral delivery of the anti-inflammatory cytokine IL13 promotes alternative activation of both microglia and macrophages after stroke.
- Author
-
Hamzei Taj S, Le Blon D, Hoornaert C, Daans J, Quarta A, Praet J, Van der Linden A, Ponsaerts P, and Hoehn M
- Subjects
- Animals, CX3C Chemokine Receptor 1 genetics, CX3C Chemokine Receptor 1 metabolism, Disease Models, Animal, Gene Expression Regulation physiology, Infarction, Middle Cerebral Artery diagnostic imaging, Infarction, Middle Cerebral Artery physiopathology, Interleukin-13 genetics, Interleukin-13 metabolism, Luminescent Proteins genetics, Luminescent Proteins metabolism, Macrophages metabolism, Mesenchymal Stem Cell Transplantation methods, Mice, Mice, Inbred C57BL, Mice, Transgenic, Microglia metabolism, Movement physiology, Muscle Strength, Proprioception, RNA, Messenger metabolism, Receptors, CCR2 genetics, Receptors, CCR2 metabolism, Touch physiology, Transduction, Genetic, Anti-Inflammatory Agents therapeutic use, Infarction, Middle Cerebral Artery pathology, Infarction, Middle Cerebral Artery therapy, Interleukin-13 therapeutic use, Macrophages drug effects, Microglia drug effects
- Abstract
Background: Subtle adjustment of the activation status of CNS resident microglia and peripheral macrophages, to promote their neuroprotective and neuroregenerative functions, may facilitate research towards curing neurodegenerative disorders. In the present study, we investigated whether targeted intracerebral delivery of the anti-inflammatory cytokine interleukin (IL)13, by means of transplanting IL13-expressing mesenchymal stem cells (IL13-MSCs), can promote a phenotypic switch in both microglia and macrophages during the pro-inflammatory phase in a mouse model of ischemic stroke., Methods: We used the CX
3 CR1eGFP/+ CCR2RFP/+ transgenic mouse model to separately recognize brain-resident microglia from infiltrated macrophages. Quantitative immunohistochemical analyses were applied to characterize polarization phenotypes of both cell types., Results: Distinct behaviors of both cell populations were noted dependent on the anatomical site of the lesion. Immunohistochemistry revealed that mice grafted with IL13-MSCs, in contrast to non-grafted and MSC-grafted control mice, were able to drive recruited microglia and macrophages into an alternative activation state, as visualized by a significant increase of Arg-1 and a noticeable decrease of MHC-II expression at day 14 after ischemic stroke. Interestingly, both Arg-1 and MHC-II were expressed more abundantly in macrophages than in microglia, further confirming the distinct behavior of both cell populations., Conclusions: The current data highlight the importance of controlled and localized delivery of the anti-inflammatory cytokine IL13 for modulation of both microglia and macrophage responses after ischemic stroke, thereby providing pre-clinical rationale for the application of L13-MSCs in future investigations of neurodegenerative disorders.- Published
- 2018
- Full Text
- View/download PDF
30. Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression.
- Author
-
Rüther BJ, Scheld M, Dreymueller D, Clarner T, Kress E, Brandenburg LO, Swartenbroekx T, Hoornaert C, Ponsaerts P, Fallier-Becker P, Beyer C, Rohr SO, Schmitz C, Chrzanowski U, Hochstrasser T, Nyamoya S, and Kipp M
- Subjects
- Amyloid beta-Protein Precursor metabolism, Animals, Disease Models, Animal, Encephalitis genetics, Encephalomyelitis, Autoimmune, Experimental immunology, Female, Freund's Adjuvant toxicity, Gene Expression drug effects, Gene Expression genetics, Glial Fibrillary Acidic Protein metabolism, Intercellular Adhesion Molecule-1 genetics, Intercellular Adhesion Molecule-1 metabolism, Luminescent Proteins genetics, Luminescent Proteins metabolism, Mice, Mice, Inbred C57BL, Mice, Transgenic, Microglia pathology, Microglia ultrastructure, Monocytes pathology, Monocytes ultrastructure, Myelin-Oligodendrocyte Glycoprotein immunology, Myelin-Oligodendrocyte Glycoprotein toxicity, Peptide Fragments immunology, Peptide Fragments toxicity, Receptors, CCR2 genetics, Receptors, CCR2 metabolism, Receptors, Interleukin-8A genetics, Receptors, Interleukin-8A metabolism, Disease Progression, Encephalitis etiology, Encephalitis pathology, Encephalomyelitis, Autoimmune, Experimental complications, Sesquiterpenes toxicity
- Abstract
Brain-intrinsic degenerative cascades are a proposed factor driving inflammatory lesion formation in multiple sclerosis (MS) patients. We recently described a model combining noninflammatory cytodegeneration (via cuprizone) with the classic active experimental autoimmune encephalomyelitis (Cup/EAE model), which exhibits inflammatory forebrain lesions. Here, we describe the histopathological characteristics and progression of these Cup/EAE lesions. We show that inflammatory lesions develop at various topographical sites in the forebrain, including white matter tracts and cortical and subcortical grey matter areas. The lesions are characterized by focal demyelination, discontinuation of the perivascular glia limitans, focal axonal damage, and neutrophil granulocyte extravasation. Transgenic mice with enhanced green fluorescent protein-expressing microglia and red fluorescent protein-expressing monocytes reveal that both myeloid cell populations contribute to forebrain inflammatory infiltrates. EAE-triggered inflammatory cerebellar lesions were augmented in mice pre-intoxicated with cuprizone. Gene expression studies suggest roles of the chemokines Cxcl10, Ccl2, and Ccl3 in inflammatory lesion formation. Finally, follow-up experiments in Cup/EAE mice with chronic disease revealed that forebrain, but not spinal cord, lesions undergo spontaneous reorganization and repair. This study underpins the significance of brain-intrinsic degenerative cascades for immune cell recruitment and, in consequence, MS lesion formation., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
31. Immune remodelling of stromal cell grafts in the central nervous system: therapeutic inflammation or (harmless) side-effect?
- Author
-
Le Blon D, Hoornaert C, Detrez JR, Bevers S, Daans J, Goossens H, De Vos WH, Berneman Z, and Ponsaerts P
- Subjects
- Animals, Humans, Models, Biological, Stromal Cells cytology, Stromal Cells immunology, Stromal Cells transplantation, Central Nervous System immunology, Central Nervous System pathology, Inflammation pathology
- Abstract
Over the past two decades, several cell types with fibroblast-like morphology, including mesenchymal stem/stromal cells, but also other adult, embryonic and extra-embryonic fibroblast-like cells, have been brought forward in the search for cellular therapies to treat severe brain injuries and/or diseases. Although current views in regenerative medicine are highly focused on the immune modulating and regenerative properties of stromal cell transplantation in vivo, many open questions remain regarding their true mode of action. In this perspective, this study integrates insights gathered over the past 10 years to formulate a unifying model of the cellular events that accompany fibroblast-like cell grafting in the rodent brain. Cellular interactions are discussed step-by-step, starting from the day of implantation up to 10 days after transplantation. During the short period that precedes stable settlement of autologous/syngeneic stromal cell grafts, there is a complex interplay between hypoxia-mediated cell death of grafted cells, neutrophil invasion, microglia and macrophage recruitment, astrocyte activation and neo-angiogenesis within the stromal cell graft site. Consequently, it is speculated that regenerative processes following cell therapeutic intervention in the CNS are not only modulated by soluble factors secreted by grafted stromal cells (bystander hypothesis), but also by in vivo inflammatory processes following stromal cell grafting. Copyright © 2016 John Wiley & Sons, Ltd., (Copyright © 2016 John Wiley & Sons, Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
32. Multipotent adult progenitor cells improve the hematopoietic function in myelodysplasia.
- Author
-
Roobrouck VD, Wolfs E, Delforge M, Broekaert D, Chakraborty S, Sels K, Vanwelden T, Holvoet B, Lhoest L, Khurana S, Pandey S, Hoornaert C, Ponsaerts P, Struys T, Boeckx N, Vandenberghe P, Deroose CM, and Verfaillie CM
- Subjects
- Adult, Animals, Bone Marrow Cells cytology, Cell Differentiation, Female, Hematopoiesis, Humans, In Situ Hybridization, Fluorescence, Mice, Inbred C57BL, Multipotent Stem Cells transplantation, Myelodysplastic Syndromes therapy
- Abstract
Background Aims: Myelodysplastic syndromes (MDS) are a group of clonal stem cell disorders affecting the normal hematopoietic differentiation process and leading to abnormal maturation and differentiation of all blood cell lineages. Treatment options are limited, and there is an unmet medical need for effective therapies for patients with severe cytopenias., Methods: We demonstrate that multipotent adult progenitor cells (MAPC) improve the function of hematopoietic progenitors derived from human MDS bone marrow (BM) by significantly increasing the frequency of primitive progenitors as well as the number of myeloid colonies., Results: This effect was more pronounced in a non-contact culture, indicating the importance of soluble factors produced by the MAPC cells. Moreover, the cells did not stimulate the growth of the abnormal MDS clone, as shown by fluorescent in situ hybridization analysis on BM cells from patients with a known genetic abnormality. We also demonstrate that MAPC cells can provide stromal support for patient-derived hematopoietic cells. When MAPC cells were intravenously injected into a mouse model of MDS, they migrated to the site of injury and increased the hematopoietic function in diseased mice., Discussion: The preclinical studies undertaken here indicate an initial proof of concept for the use of MAPC cell therapy in patients with MDS-related severe and symptomatic cytopenias and should pave the way for further investigation in clinical trials., (Copyright © 2017. Published by Elsevier Inc.)
- Published
- 2017
- Full Text
- View/download PDF
33. Intracerebral delivery of the M2 polarizing cytokine interleukin 13 using mesenchymal stem cell implants in a model of temporal lobe epilepsy in mice.
- Author
-
Ali I, Aertgeerts S, Le Blon D, Bertoglio D, Hoornaert C, Ponsaerts P, and Dedeurwaerdere S
- Subjects
- Animals, Drug Delivery Systems, Electrodes, Implanted, Electroencephalography drug effects, Genetic Engineering, Injections, Interleukin-13 genetics, Interleukin-13 metabolism, Male, Mice, Inbred C57BL, Disease Models, Animal, Epilepsy, Temporal Lobe physiopathology, Hippocampus drug effects, Hippocampus physiopathology, Interleukin-13 pharmacology, Macrophage Activation, Mesenchymal Stem Cell Transplantation, Microglia drug effects, Neuroprotective Agents pharmacology
- Abstract
Objectives: Neuroinflammation plays a critical role in the pathophysiology of mesial temporal lobe epilepsy. We aimed to evaluate whether intracerebral transplantation of interleukin 13-producing mesenchymal stem cells (IL-13 MSCs) induces an M2 microglia/macrophage activation phenotype in the hippocampus with an epileptogenic insult, thereby providing a neuroprotective environment with reduced epileptogenesis., Methods: Genetically engineered syngeneic IL-13 MSCs or vehicle was injected within the hippocampus 1 week before the intrahippocampal kainic acid-induced status epilepticus (SE) in C57BL/6J mice. Neuroinflammation was evaluated at disease onset as well as during the chronic epilepsy period (9 weeks). In addition, continuous video-electroencephalography (EEG) (vEEG) monitoring was obtained during the chronic epilepsy period (between 6 and 9 weeks after SE)., Results: Evaluation of vEEG recordings suggested that IL-13 MSC grafts did not affect the severity and duration of SE or the seizure burden during the chronic epilepsy period, when compared to the vehicle treated SE mice. An M2-activation phenotype was induced in microglia/macrophages that infiltrated the -13 MSC graft site, as evidenced by the arginase1 expression at the graft site at both the 2-week and 9-week time-points. However, M2-activated immune cells were rarely observed outside the graft site and, accordingly, the neuroinflammatory response or cell loss related to SE induction was not altered by IL-13 MSC grafting. Moreover, an increase in the proportion of F4/80
+ cells was observed in the IL-13 MSC group compared to the controls., Significance: Our data suggest that MSC-based IL-13 delivery to induce M2 glial activation does not provide any neuroprotective or disease-modifying effects in a mouse model of epilepsy. Moreover, use of cell grafting to deliver bioactive compounds for modulating neuroinflammation may have confounding effects in disease pathology of epilepsy due to the additional immune response generated by the grafted cells., (Wiley Periodicals, Inc. © 2017 International League Against Epilepsy.)- Published
- 2017
- Full Text
- View/download PDF
34. Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcome after Spinal Cord Injury.
- Author
-
Dooley D, Lemmens E, Vangansewinkel T, Le Blon D, Hoornaert C, Ponsaerts P, and Hendrix S
- Subjects
- Animals, Axons drug effects, Axons pathology, CD4-Positive T-Lymphocytes drug effects, CD4-Positive T-Lymphocytes immunology, Cell Count, Demyelinating Diseases pathology, Demyelinating Diseases physiopathology, Interleukin-13 pharmacology, Interleukin-13 therapeutic use, Macrophages drug effects, Macrophages pathology, Mice, Inbred BALB C, Mice, Inbred C57BL, Microglia drug effects, Microglia pathology, Neuroprotective Agents pharmacology, Neuroprotective Agents therapeutic use, Recovery of Function drug effects, Spinal Cord Injuries immunology, Spinal Cord Injuries pathology, Treatment Outcome, Interleukin-13 administration & dosage, Macrophage Activation drug effects, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells metabolism, Spinal Cord Injuries physiopathology, Spinal Cord Injuries therapy
- Abstract
The therapeutic effects of mesenchymal stem cell (MSC) transplantation following spinal cord injury (SCI) to date have been limited. Therefore, we aimed to enhance the immunomodulatory properties of MSCs via continuous secretion of the anti-inflammatory cytokine interleukin-13 (IL-13). By using MSCs as carriers of IL-13 (MSC/IL-13), we investigated their therapeutic potential, compared with non-engineered MSCs, in a mouse model of SCI. We show that transplanted MSC/IL-13 significantly improve functional recovery following SCI, and also decrease lesion size and demyelinated area by more than 40%. Further histological analyses in CX
3 CR1EGFP/+ CCR2RFP/+ transgenic mice indicated that MSC/IL-13 significantly decrease the number of resident microglia and increase the number of alternatively activated macrophages. In addition, the number of macrophage-axon contacts in MSC/IL-13-treated mice was decreased by 50%, suggesting a reduction in axonal dieback. Our data provide evidence that transplantation of MSC/IL-13 leads to improved functional and histopathological recovery in a mouse model of SCI., (Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2016
- Full Text
- View/download PDF
35. Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages.
- Author
-
Guglielmetti C, Le Blon D, Santermans E, Salas-Perdomo A, Daans J, De Vocht N, Shah D, Hoornaert C, Praet J, Peerlings J, Kara F, Bigot C, Mai Z, Goossens H, Hens N, Hendrix S, Verhoye M, Planas AM, Berneman Z, van der Linden A, and Ponsaerts P
- Subjects
- Animals, Antigens, Differentiation metabolism, Bone Marrow Transplantation, Cuprizone toxicity, Cytokines genetics, Cytokines metabolism, Demyelinating Diseases chemically induced, Demyelinating Diseases diagnostic imaging, Disease Models, Animal, Encephalitis chemically induced, Encephalitis diagnostic imaging, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Mice, Mice, Inbred C57BL, Mice, Transgenic, Monoamine Oxidase Inhibitors toxicity, Myelin Proteins metabolism, Nerve Tissue Proteins genetics, Nerve Tissue Proteins metabolism, Transduction, Genetic, Demyelinating Diseases therapy, Encephalitis therapy, Genetic Therapy methods, Interleukin-13 genetics, Interleukin-13 metabolism, Interleukin-13 therapeutic use, Macrophages drug effects, Microglia drug effects
- Abstract
Detrimental inflammatory responses in the central nervous system are a hallmark of various brain injuries and diseases. With this study we provide evidence that lentiviral vector-mediated expression of the immune-modulating cytokine interleukin 13 (IL-13) induces an alternative activation program in both microglia and macrophages conferring protection against severe oligodendrocyte loss and demyelination in the cuprizone mouse model for multiple sclerosis (MS). First, IL-13 mediated modulation of cuprizone induced lesions was monitored using T
2 -weighted magnetic resonance imaging and magnetization transfer imaging, and further correlated with quantitative histological analyses for inflammatory cell influx, oligodendrocyte death, and demyelination. Second, following IL-13 immune gene therapy in cuprizone-treated eGFP+ bone marrow chimeric mice, we provide evidence that IL-13 directs the polarization of both brain-resident microglia and infiltrating macrophages towards an alternatively activated phenotype, thereby promoting the conversion of a pro-inflammatory environment toward an anti-inflammatory environment, as further evidenced by gene expression analyses. Finally, we show that IL-13 immune gene therapy is also able to limit lesion severity in a pre-existing inflammatory environment. In conclusion, these results highlight the potential of IL-13 to modulate microglia/macrophage responses and to improve disease outcome in a mouse model for MS. GLIA 2016;64:2181-2200., (© 2016 Wiley Periodicals, Inc.)- Published
- 2016
- Full Text
- View/download PDF
36. Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model.
- Author
-
Le Blon D, Guglielmetti C, Hoornaert C, Quarta A, Daans J, Dooley D, Lemmens E, Praet J, De Vocht N, Reekmans K, Santermans E, Hens N, Goossens H, Verhoye M, Van der Linden A, Berneman Z, Hendrix S, and Ponsaerts P
- Subjects
- Animals, Cell Line, Transformed, Cytokines genetics, Cytokines metabolism, Disease Models, Animal, Glial Fibrillary Acidic Protein metabolism, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Magnetic Resonance Imaging, Mesenchymal Stem Cells metabolism, Mice, Mice, Inbred C57BL, Mice, Transgenic, Myelin Basic Protein metabolism, Oligodendroglia drug effects, Cuprizone toxicity, Demyelinating Diseases chemically induced, Demyelinating Diseases diagnostic imaging, Demyelinating Diseases pathology, Demyelinating Diseases surgery, Gliosis etiology, Interleukin-13 metabolism, Mesenchymal Stem Cell Transplantation, Monoamine Oxidase Inhibitors toxicity, Oligodendroglia pathology
- Abstract
Background: Promoting the neuroprotective and repair-inducing effector functions of microglia and macrophages, by means of M2 polarisation or alternative activation, is expected to become a new therapeutic approach for central nervous system (CNS) disorders in which detrimental pro-inflammatory microglia and/or macrophages display a major contribution to the neuropathology. In this study, we present a novel in vivo approach using intracerebral grafting of mesenchymal stem cells (MSC) genetically engineered to secrete interleukin 13 (IL13-MSC)., Methods: In the first experimental setup, control MSC and IL13-MSC were grafted in the CNS of eGFP
+ bone marrow chimaeric C57BL/6 mice to histologically evaluate IL13-mediated expression of several markers associated with alternative activation, including arginase1 and Ym1, on MSC graft-recognising microglia and MSC graft-infiltrating macrophages. In the second experimental setup, IL13-MSC were grafted on the right side (or on both the right and left sides) of the splenium of the corpus callosum in wild-type C57BL/6 mice and in C57BL/6 CX3 CR1eGFP/+ CCR2RFP/+ transgenic mice. Next, CNS inflammation and demyelination was induced by means of a cuprizone-supplemented diet. The influence of IL13-MSC grafting on neuropathological alterations was monitored by non-invasive T2 -weighted magnetic resonance imaging (MRI) and quantitative histological analyses, as compared to cuprizone-treated mice with control MSC grafts and/or cuprizone-treated mice without MSC injection., Results: In the first part of this study, we demonstrate that MSC graft-associated microglia and MSC graft-infiltrating macrophages are forced into alternative activation upon grafting of IL13-MSC, but not upon grafting of control MSC. In the second part of this study, we demonstrate that grafting of IL13-MSC, in addition to the recruitment of M2 polarised macrophages, limits cuprizone-induced microgliosis, oligodendrocyte death and demyelination. Furthermore, we here demonstrate that injection of IL13-MSC at both sides of the splenium leads to a superior protective effect as compared to a single injection at one side of the splenium., Conclusions: Controlled and localised production of IL13 by means of intracerebral MSC grafting has the potential to modulate cell graft- and pathology-associated microglial/macrophage responses, and to interfere with oligodendrocyte death and demyelinating events in the cuprizone mouse model.- Published
- 2016
- Full Text
- View/download PDF
37. Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.
- Author
-
Baranowska M, Hauge AG, Hoornaert C, Bogen B, and Grødeland G
- Subjects
- Animals, Antibodies, Viral blood, Antibody Formation, Antigen-Presenting Cells immunology, CD8-Positive T-Lymphocytes immunology, Chemokine CCL3 immunology, Female, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H7N7 Subtype, Mice, Inbred BALB C, Neutralization Tests, Orthomyxoviridae Infections immunology, Plasmids, Cross Protection, Influenza Vaccines immunology, Nucleoproteins immunology, Orthomyxoviridae Infections prevention & control, Receptors, Chemokine immunology, Vaccines, DNA immunology
- Abstract
Vaccination is at present the most efficient way of preventing influenza infections. Currently used inactivated influenza vaccines can induce virus-neutralizing antibodies that are protective against a particular influenza strain, but hamper the induction of cross-protective T-cell responses to later infections. Thus, influenza vaccines need to be updated annually in order to confer protection against circulating influenza strains. This study aims at developing an efficient vaccine that can induce broader protection against influenza. For this purpose, we have used the highly conserved nucleoprotein (NP) from an influenza A virus subtype H7N7 strain, and inserted it into a vaccine format that targets an antigen directly to relevant antigen presenting cells (APCs). The vaccine format consists of bivalent antigenic and targeting units, linked via an Ig-based dimerization unit. In this study, NP was linked to MIP-1α, a chemokine that targets the linked antigen to chemokine receptors 1, 3 and 5 expressed on various APCs. The vaccine protein was indirectly delivered by DNA. Mice were vaccinated intradermally with plasmids, in combination with electroporation to enhance cellular uptake of DNA. We found that a single DNA vaccination was sufficient for induction of both antibody and T cell responses in BALB/c mice. Targeting of nucleoprotein to chemokine receptors enhanced T cell responses but not antibody responses. Moreover, a single dose of MIP1α-NP conferred protection in BALB/c mice against a lethal challenge with an H1N1 influenza virus. The observed cross-protection was mediated by CD8(+) T cells., (Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
38. Early Inflammatory Responses Following Cell Grafting in the CNS Trigger Activation of the Subventricular Zone: A Proposed Model of Sequential Cellular Events.
- Author
-
Praet J, Santermans E, Daans J, Le Blon D, Hoornaert C, Goossens H, Hens N, Van der Linden A, Berneman Z, and Ponsaerts P
- Subjects
- Animals, Apoptosis, Cell Proliferation, Cells, Cultured, Central Nervous System immunology, Female, Fibroblasts cytology, Fibroblasts metabolism, Fibroblasts transplantation, Genes, Reporter, Graft Survival, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Hypoxia, Macrophages cytology, Macrophages immunology, Mice, Mice, Inbred C57BL, Mice, Transgenic, Microglia metabolism, Models, Biological, Neural Stem Cells cytology, Neural Stem Cells metabolism, Neutrophils cytology, Central Nervous System metabolism, Inflammation, Lateral Ventricles cytology, Neutrophils immunology
- Abstract
While multiple rodent preclinical studies, and to a lesser extent human clinical trials, claim the feasibility, safety, and potential clinical benefit of cell grafting in the central nervous system (CNS), currently only little convincing knowledge exists regarding the actual fate of the grafted cells and their effect on the surrounding environment (or vice versa). Our preceding studies already indicated that only a minor fraction of the initially grafted cell population survives the grafting process, while the surviving cell population becomes invaded by highly activated microglia/macrophages and surrounded by reactive astrogliosis. In the current study, we further elaborate on early cellular and inflammatory events following syngeneic grafting of eGFP(+) mouse embryonic fibroblasts (mEFs) in the CNS of immunocompetent mice. Based on obtained quantitative histological data, we here propose a detailed mathematically derived working model that sequentially comprises hypoxia-induced apoptosis of grafted mEFs, neutrophil invasion, neoangiogenesis, microglia/macrophage recruitment, astrogliosis, and eventually survival of a limited number of grafted mEFs. Simultaneously, we observed that the cellular events following mEF grafting activates the subventricular zone neural stem and progenitor cell compartment. This proposed model therefore further contributes to our understanding of cell graft-induced cellular responses and will eventually allow for successful manipulation of this intervention.
- Published
- 2015
- Full Text
- View/download PDF
39. Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain.
- Author
-
Costa R, Bergwerf I, Santermans E, De Vocht N, Praet J, Daans J, Le Blon D, Hoornaert C, Reekmans K, Hens N, Goossens H, Berneman Z, Parolini O, Alviano F, and Ponsaerts P
- Subjects
- Animals, Cell Differentiation, Cells, Cultured, Coculture Techniques, Female, Fibroblasts cytology, Fibroblasts metabolism, Immunophenotyping, Interferon-gamma pharmacology, Lipopolysaccharides toxicity, Mice, Mice, Inbred C57BL, Microglia cytology, Microglia drug effects, Microglia metabolism, Stromal Cells cytology, Stromal Cells metabolism, Transplantation, Homologous, Tumor Necrosis Factor-alpha metabolism, Vascular Endothelial Growth Factor A metabolism, Brain pathology, Embryo, Mammalian cytology, Extraembryonic Membranes cytology, Fibroblasts transplantation, Stromal Cells transplantation
- Abstract
Although intracerebral transplantation of various fibroblast(-like) cell populations has been shown feasible, little is known about the actual in vivo remodeling of these cellular grafts and their environment. In this study, we aimed to compare the in vitro and in vivo behavior of two phenotypically similar-but developmentally distinct-fibroblast-like cell populations, namely, mouse embryonic fibroblasts (mEFs) and mouse fetal membrane-derived stromal cells (mFMSCs). While both mEFs and mFMSCs are readily able to reduce TNF-α secretion by LPS/IFN-γ-activated BV-2 microglia, mFMSCs and mEFs display strikingly opposite behavior with regard to VEGF production under normal and inflammatory conditions. Whereas mFMSCs downregulate VEGF production upon coculture with LPS/IFN-γ-activated BV-2 microglia, mEFs upregulate VEGF production in the presence of LPS/IFN-γ-activated BV-2 microglia. Subsequently, in vivo grafting of mFMSCs and mEFs revealed no difference in microglial and astroglial responses toward the cellular grafts. However, mFMSC grafts displayed a lower degree of neoangiogenesis compared to mEF grafts, thereby potentially explaining the lower cell number able to survive in mFMSC grafts. In summary, our results suggest that physiological differences between fibroblast-like cell populations might lie at the basis of variations in histopathological and/or clinical outcome following cell grafting in mouse brain.
- Published
- 2015
- Full Text
- View/download PDF
40. Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain.
- Author
-
Le Blon D, Hoornaert C, Daans J, Santermans E, Hens N, Goossens H, Berneman Z, and Ponsaerts P
- Subjects
- Animals, Brain immunology, Brain pathology, CX3C Chemokine Receptor 1, Calcium-Binding Proteins metabolism, Gene Expression, Genes, Reporter, Histocompatibility Antigens Class II immunology, Histocompatibility Antigens Class II metabolism, Immunophenotyping, Macrophages immunology, Mice, Mice, Transgenic, Microfilament Proteins metabolism, Microglia immunology, Myeloid Cells metabolism, Receptors, Cytokine genetics, Receptors, Cytokine metabolism, Receptors, HIV genetics, Receptors, HIV metabolism, Signal Transduction, Transduction, Genetic, Transplantation Chimera, Brain metabolism, Macrophages metabolism, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells metabolism, Microglia metabolism
- Abstract
Although implantation of cellular material in the central nervous system (CNS) is a key direction in CNS regenerative medicine, this approach is currently limited by the occurrence of strong endogenous immune cell responses. In a model of mesenchymal stem cell (MSC) grafting in the CNS of immune-competent mice, we previously described that MSC grafts become highly surrounded and invaded by Iba1(+) myeloid cells (microglia and/or macrophages). Here, following grafting of blue fluorescent protein (BFP)-expressing MSC in the CNS of CX3CR1(+/-) and CX3CR1(-/-) mice, our results indicate: (1) that the observed inflammatory response is independent of the fractalkine signalling axis, and (2) that a significant spatial distribution of Iba1(+) inflammatory cells occurs, in which Iba1(+) CX3CR1(+) myeloid cells mainly surround the MSC graft and Iba1(+) CX3CR1(-) myeloid cells mainly invade the graft at 10 days post transplantation. Although Iba1(+) CX3CR1(+) myeloid cells are considered to be of resident microglial origin, Iba1(+) CX3CR1(-) myeloid cells are most likely of peripheral monocyte/macrophage origin. In order to confirm the latter, we performed MSC-BFP grafting experiments in the CNS of eGFP(+) bone marrow chimeric C57BL/6 mice. Analysis of MSC-BFP grafts in the CNS of these mice confirmed our observation that peripheral monocytes/macrophages invade the MSC graft and that resident microglia surround the MSC graft site. Furthermore, analysis of major histocompatibility complex class II (MHCII) expression revealed that mainly macrophages, but not microglia, express this M1 pro-inflammatory marker in the context of MSC grafting in the CNS. These results again highlight the complexity of cell implantation immunology in the CNS.
- Published
- 2014
- Full Text
- View/download PDF
41. Histological characterization and quantification of cellular events following neural and fibroblast(-like) stem cell grafting in healthy and demyelinated CNS tissue.
- Author
-
Praet J, Santermans E, Reekmans K, de Vocht N, Le Blon D, Hoornaert C, Daans J, Goossens H, Berneman Z, Hens N, Van der Linden A, and Ponsaerts P
- Subjects
- Animals, Cell Culture Techniques, Cell Differentiation, Cell- and Tissue-Based Therapy, Disease Models, Animal, Female, Fibroblasts cytology, Fibroblasts metabolism, Flow Cytometry, Gene Expression, Genes, Reporter, Graft Survival, Immunohistochemistry, Mice, Neural Stem Cells metabolism, Regenerative Medicine, Transgenes, Demyelinating Diseases therapy, Neural Stem Cells cytology, Stem Cell Transplantation
- Abstract
Preclinical animal studies involving intracerebral (stem) cell grafting are gaining popularity in many laboratories due to the reported beneficial effects of cell grafting on various diseases or traumata of the central nervous system (CNS). In this chapter, we describe a histological workflow to characterize and quantify cellular events following neural and fibroblast(-like) stem cell grafting in healthy and demyelinated CNS tissue. First, we provide standardized protocols to isolate and culture eGFP(+) neural and fibroblast(-like) stem cells from embryonic mouse tissue. Second, we describe flow cytometric procedures to determine cell viability, eGFP transgene expression, and the expression of different stem cell lineage markers. Third, we explain how to induce reproducible demyelination in the CNS of mice by means of cuprizone administration, a validated mouse model for human multiple sclerosis. Fourth, the technical procedures for cell grafting in the CNS are explained in detail. Finally, an optimized and validated workflow for the quantitative histological analysis of cell graft survival and endogenous astroglial and microglial responses is provided.
- Published
- 2014
- Full Text
- View/download PDF
42. Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system.
- Author
-
De Vocht N, Praet J, Reekmans K, Le Blon D, Hoornaert C, Daans J, Berneman Z, Van der Linden A, and Ponsaerts P
- Subjects
- Central Nervous System, Humans, Mesenchymal Stem Cells pathology, Mesenchymal Stem Cell Transplantation methods, Mesenchymal Stem Cells physiology
- Abstract
Over the past decade a lot of research has been performed towards the therapeutic use of mesenchymal stem cells (MSCs) in neurodegenerative and neuroinflammatory diseases. MSCs have shown to be beneficial in different preclinical studies of central nervous system (CNS) disorders due to their immunomodulatory properties and their capacity to secrete various growth factors. Nevertheless, most of the transplanted cells die within the first hours after transplantation and induce a neuroinflammatory response. In order to increase the efficacy of MSC transplantation, it is thus imperative to completely characterise the mechanisms mediating neuroinflammation and cell death following MSC transplantation into the CNS. Consequently, different components of these cell death- and neuroinflammation-inducing pathways can be targeted in an attempt to improve the therapeutic potential of MSCs for CNS disorders.
- Published
- 2013
- Full Text
- View/download PDF
43. Quantitative and phenotypic analysis of mesenchymal stromal cell graft survival and recognition by microglia and astrocytes in mouse brain.
- Author
-
De Vocht N, Lin D, Praet J, Hoornaert C, Reekmans K, Le Blon D, Daans J, Pauwels P, Goossens H, Hens N, Berneman Z, Van der Linden A, and Ponsaerts P
- Subjects
- Animals, Astrocytes immunology, Brain immunology, CD11b Antigen genetics, CD11b Antigen immunology, Cell Count, Cells, Cultured, Gene Expression, Genes, Reporter, Green Fluorescent Proteins, Luciferases, Male, Mesenchymal Stem Cells immunology, Mice, Mice, Transgenic, Microglia immunology, Nitric Oxide Synthase Type II genetics, Nitric Oxide Synthase Type II immunology, Transplantation, Autologous, Astrocytes cytology, Brain cytology, Graft Survival immunology, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells cytology, Microglia cytology
- Abstract
Although cell transplantation is increasingly suggested to be beneficial for the treatment of various neurodegenerative diseases, the therapeutic application of such intervention is currently hindered by the limited knowledge regarding central nervous system (CNS) transplantation immunology. In this study, we aimed to investigate the early post transplantation innate immune events following grafting of autologous mesenchymal stromal cells (MSC) in the CNS of immune competent mice. First, the survival of grafted Luciferase/eGFP-expressing MSC (MSC-Luc/eGFP) was demonstrated to be stable from on day 3 post implantation using in vivo bioluminescence imaging (BLI), which was further confirmed by quantitative histological analysis of MSC-Luc/eGFP graft survival. Additional histological analyses at week 1 and week 2 post grafting revealed the appearance of (i) graft-surrounding/-invading Iba1+ microglia and (ii) graft-surrounding GFAP+ astrocytes, as compared to day 0 post grafting. While the density of graft-surrounding astrocytes and microglia did not change between week 1 and week 2 post grafting, the density of graft-invading microglia significantly decreased between week 1 and week 2 post implantation. However, despite the observed decrease in microglial density within the graft site, additional phenotypic analysis of graft-invading microglia, based on CD11b- and MHCII-expression, revealed >50% of graft-invading microglia at week 2 post implantation to display an activated status. Although microglial expression of CD11b and MHCII is already suggestive for a pro-inflammatory M1-oriented phenotype, the latter was further confirmed by: (i) the expression of NOS2 by microglia within the graft site, and (ii) the absence of arginase 1-expression, an enzyme known to suppress NO activity in M2-oriented microglia, on graft-surrounding and -invading microglia. In summary, we here provide a detailed phenotypic analysis of post transplantation innate immune events in the CNS of mice, and warrant that such intervention is associated with an M1-oriented microglia response and severe astrogliosis., (Copyright © 2012 Elsevier GmbH. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
44. Quantitative evaluation of stem cell grafting in the central nervous system of mice by in vivo bioluminescence imaging and postmortem multicolor histological analysis.
- Author
-
Reekmans K, De Vocht N, Praet J, Le Blon D, Hoornaert C, Daans J, Van der Linden A, Berneman Z, and Ponsaerts P
- Subjects
- Animals, Astrocytes cytology, Cell Differentiation, Cell Survival, Cell- and Tissue-Based Therapy, Cells, Cultured, Graft Survival, Mesenchymal Stem Cells cytology, Mice, Microglia cytology, Neural Stem Cells cytology, Neurons metabolism, Oligodendroglia metabolism, Central Nervous System cytology, Luminescent Measurements methods, Mesenchymal Stem Cell Transplantation, Neural Stem Cells transplantation
- Abstract
Stem cell transplantation in the central nervous system (CNS) is currently under intensive investigation as a novel therapeutic approach for a variety of brain disorders and/or injuries. However, one of the main hurdles at the moment is the lack of standardized procedures to evaluate cell graft survival and behavior following transplantation into CNS tissue, thereby leading to the publication of confusing and/or conflicting research results. In this chapter, we therefore provide validated in vivo bioluminescence and postmortem histological procedures to quantitatively determine: (a) the survival of grafted stem cells, and (b) the microglial and astroglial cell responses following cell grafting.
- Published
- 2013
- Full Text
- View/download PDF
45. Spatiotemporal evolution of early innate immune responses triggered by neural stem cell grafting.
- Author
-
Reekmans K, De Vocht N, Praet J, Fransen E, Le Blon D, Hoornaert C, Daans J, Goossens H, Van der Linden A, Berneman Z, and Ponsaerts P
- Subjects
- Animals, Brain metabolism, Brain pathology, Cell Survival, Cells, Cultured, Graft Survival, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, Immunity, Innate, Mice, Neural Stem Cells metabolism, Neural Stem Cells transplantation, Spatio-Temporal Analysis, Neural Stem Cells cytology
- Abstract
Introduction: Transplantation of neural stem cells (NSCs) is increasingly suggested to become part of future therapeutic approaches to improve functional outcome of various central nervous system disorders. However, recently it has become clear that only a small fraction of grafted NSCs display long-term survival in the (injured) adult mouse brain. Given the clinical invasiveness of NSC grafting into brain tissue, profound characterisation and understanding of early post-transplantation events is imperative to claim safety and efficacy of cell-based interventions., Methods: Here, we applied in vivo bioluminescence imaging (BLI) and post-mortem quantitative histological analysis to determine the localisation and survival of grafted NSCs at early time points post-transplantation., Results: An initial dramatic cell loss (up to 80% of grafted cells) due to apoptosis could be observed within the first 24 hours post-implantation, coinciding with a highly hypoxic NSC graft environment. Subsequently, strong spatiotemporal microglial and astroglial cell responses were initiated, which stabilised by day 5 post-implantation and remained present during the whole observation period. Moreover, the increase in astrocyte density was associated with a high degree of astroglial scarring within and surrounding the graft site. During the two-week follow up in this study, the NSC graft site underwent extensive remodelling with NSC graft survival further declining to around 1% of the initial number of grafted cells., Conclusions: The present study quantitatively describes the early post-transplantation events following NSC grafting in the adult mouse brain and warrants that such intervention is directly associated with a high degree of cell loss, subsequently followed by strong glial cell responses.
- Published
- 2012
- Full Text
- View/download PDF
46. Multimodal imaging of stem cell implantation in the central nervous system of mice.
- Author
-
De Vocht N, Reekmans K, Bergwerf I, Praet J, Hoornaert C, Le Blon D, Daans J, Berneman Z, Van der Linden A, and Ponsaerts P
- Subjects
- Animals, Ferric Compounds analysis, Graft Survival, Green Fluorescent Proteins analysis, Green Fluorescent Proteins biosynthesis, Green Fluorescent Proteins genetics, Luciferases, Firefly analysis, Luciferases, Firefly biosynthesis, Luciferases, Firefly genetics, Mice, Central Nervous System cytology, Central Nervous System surgery, Luminescent Measurements methods, Magnetic Resonance Imaging methods, Stem Cell Transplantation
- Abstract
During the past decade, stem cell transplantation has gained increasing interest as primary or secondary therapeutic modality for a variety of diseases, both in preclinical and clinical studies. However, to date results regarding functional outcome and/or tissue regeneration following stem cell transplantation are quite diverse. Generally, a clinical benefit is observed without profound understanding of the underlying mechanism(s). Therefore, multiple efforts have led to the development of different molecular imaging modalities to monitor stem cell grafting with the ultimate aim to accurately evaluate survival, fate and physiology of grafted stem cells and/or their micro-environment. Changes observed in one or more parameters determined by molecular imaging might be related to the observed clinical effect. In this context, our studies focus on the combined use of bioluminescence imaging (BLI), magnetic resonance imaging (MRI) and histological analysis to evaluate stem cell grafting. BLI is commonly used to non-invasively perform cell tracking and monitor cell survival in time following transplantation, based on a biochemical reaction where cells expressing the Luciferase-reporter gene are able to emit light following interaction with its substrate (e.g. D-luciferin). MRI on the other hand is a non-invasive technique which is clinically applicable and can be used to precisely locate cellular grafts with very high resolution, although its sensitivity highly depends on the contrast generated after cell labeling with an MRI contrast agent. Finally, post-mortem histological analysis is the method of choice to validate research results obtained with non-invasive techniques with highest resolution and sensitivity. Moreover end-point histological analysis allows us to perform detailed phenotypic analysis of grafted cells and/or the surrounding tissue, based on the use of fluorescent reporter proteins and/or direct cell labeling with specific antibodies. In summary, we here visually demonstrate the complementarities of BLI, MRI and histology to unravel different stem cell- and/or environment-associated characteristics following stem cell grafting in the CNS of mice. As an example, bone marrow-derived stromal cells, genetically engineered to express the enhanced Green Fluorescent Protein (eGFP) and firefly Luciferase (fLuc), and labeled with blue fluorescent micron-sized iron oxide particles (MPIOs), will be grafted in the CNS of immune-competent mice and outcome will be monitored by BLI, MRI and histology (Figure 1).
- Published
- 2012
- Full Text
- View/download PDF
47. Pharmacological profile of SL 59.1227, a novel inhibitor of the sodium/hydrogen exchanger.
- Author
-
Lorrain J, Briand V, Favennec E, Duval N, Grosset A, Janiak P, Hoornaert C, Cremer G, Latham C, and O'Connor SE
- Subjects
- Animals, Anti-Arrhythmia Agents pharmacology, Anti-Arrhythmia Agents therapeutic use, Arrhythmias, Cardiac drug therapy, Arrhythmias, Cardiac physiopathology, Benzamides chemistry, Benzamides therapeutic use, Blood Pressure drug effects, Blood Pressure physiology, Coronary Disease drug therapy, Coronary Disease physiopathology, Guanidines pharmacology, Guanidines therapeutic use, Heart Rate drug effects, Heart Rate physiology, Heart Ventricles, Hydrogen-Ion Concentration drug effects, Imidazoles chemistry, Imidazoles therapeutic use, Male, Myocardial Ischemia drug therapy, Myocardial Ischemia physiopathology, Myocardial Reperfusion Injury, Piperidines chemistry, Piperidines therapeutic use, Rabbits, Rats, Rats, Sprague-Dawley, Sodium-Hydrogen Exchangers physiology, Sulfones pharmacology, Sulfones therapeutic use, Benzamides pharmacology, Imidazoles pharmacology, Piperidines pharmacology, Sodium-Hydrogen Exchangers antagonists & inhibitors
- Abstract
1. The NHE1 isoform of the Na(+)/H(+) exchanger plays an important role in the regulation of intracellular pH and in cardiac cell injury caused by ischaemia and reperfusion. SL 59.1227 is a novel imidazolypiperidine Na(+)/H(+) antiport inhibitor which is structurally unrelated to previously described acylguanidine inhibitors such as cariporide. 2. Recovery of pH(i) following an intracellular acid load was measured in CCL39-derived PS120 variant cells, selectively expressing either NHE1 or NHE2 isoforms of the Na(+)/H(+) exchanger. pH(i) recovery was potently and selectively slowed by SL 59.1227 in NHE1-expressing cells (IC(50) 3.3+/-1.3 nM) versus NHE2-expressing cells (2.3+/-1.0 microM). The respective IC(50) values for cariporide were 103+/-28 nM (NHE1) and 73+/-46 microM (NHE2). 3. In anaesthetized rats following left coronary artery occlusion (7 min) and reperfusion (10 min) SL 59.1227 (10 - 100 microg kg(-1) min(-1) i.v.) inhibited ischaemia-mediated ventricular tachycardia (71 - 100%) and reperfusion-induced ventricular fibrillation (75 - 87%) and prevented mortality. Bolus i.v. administration of SL 59.1227 (1 mg kg(-1)) produced anti-arrhythmic effects when administered either before or during ischaemia. 4. Cardiac infarct size was determined in anaesthetized rabbits following left coronary artery occlusion (30 min) and reperfusion (120 min). Infarct size measured as a percentage of the area at risk was 36.2+/-3.4% (control group) versus 15.3+/-3.9% (SL 59.1227 0.6 mg kg(-1) i.v.). 5. SL 59.1227 is the first example of a potent and NHE1-selective non-acylguanidine Na(+)/H(+) exchanger inhibitor. It possesses marked cardioprotective properties.
- Published
- 2000
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.